Position in GILD
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$442,278,438
-$65,167,732 QoQ
Shares Held
3,500,700
-3.9% QoQ
Ownership
0.282%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#44
of 2,275 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Swiss National Bank holds $9,526,453,117 across 11 Drug Manufacturers - General names. GILD ranks #7 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,265,150 | $2,716,889,091 | |
| 2 | JNJ |
Johnson & Johnson
|
6,793,407 | $1,725,321,575 | |
| 3 | ABBV |
AbbVie Inc.
|
4,988,710 | $1,255,358,984 | |
| 4 | AZN |
Astrazeneca PLC
|
5,934,315 | $1,125,264,810 | |
| 5 | MRK |
Merck & Co., Inc.
|
6,973,251 | $896,062,753 | |
| 6 | AMGN |
Amgen Inc
|
1,520,393 | $550,564,713 | |
| 7 | GILD |
Gilead Sciences, Inc.
This page
|
3,500,700 | $442,278,438 | |
| 8 | PFE |
Pfizer Inc
|
16,043,812 | $386,334,992 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $442,278,438 | 3,500,700 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $507,446,170 | 3,641,000 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $417,340,548 | 3,400,200 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $398,001,600 | 3,585,600 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $418,390,119 | 3,773,700 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $393,855,750 | 3,515,000 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $324,865,290 | 3,517,000 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $310,031,936 | 3,697,900 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $253,308,120 | 3,692,000 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $273,332,375 | 3,731,500 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $315,639,263 | 3,896,300 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $300,674,268 | 4,012,200 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $347,601,114 | 4,510,200 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $412,983,175 | 4,977,500 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $437,319,900 | 5,094,000 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $335,340,547 | 5,435,898 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $336,196,828 | 5,439,198 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $322,997,676 | 5,433,098 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $346,037,331 | 4,765,698 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $346,392,995 | 4,959,098 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $352,831,616 | 5,123,898 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $413,129,372 | 6,392,223 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $366,392,653 | 6,288,923 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $394,161,716 | 6,237,723 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $442,245,195 | 5,747,923 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $380,589,927 | 5,090,823 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||